New listing ironclad strategy - GSP.doc

 PAGE \* MERGEFORMAT 13 New listing ironclad strategy - ‘GSP’ Currently there are 4488 non-prescription drugs, more than 5,000 prescription drugs, the annual continuous casting process is still new, but not every new listing will be successful, a lot of production approval number 100 can be a real product manufacturing operations arePitiful! New listing in order to gain market recognition, grab market share, the author based on years of practical experience, summed up new listing ‘GSP’ rule that the Goods value (of goods the law of value), Strength transmission (edge propagation), Place Promotion ( channel marketing law). 1, Goods value of goods the law of value Drugs as a special commodity, profit from business in order, we must consider two issues, namely, the value of products hidden in the interests of consumers and channel the interests of value. The interests of consumers value: Each one ready to develop new pharmaceutical companies should first ask themselves, upcoming product offerings designed to be a big benefit to the consumer value, whether the value of such benefits can replace existing drugs, whether the value of such benefits can be to stimulate consumers to buy impulse, the value of such benefits that consumers can easily access, so that each new value hidden in the interests of consumers as the product of the most basic elements of success. For example, the same Qingrejiedu proprietary Chinese medicines, the effectiveness of new products in the same situation than the existing similar products have to take less, high security value of the interests of consumers, so that the interests of consumers of products from the market value for the success of doing minimum protection.Another example is the same as the swelling pain of the bone-medicated oil over existing products with new units of the active ingredients more swelling and faster onset of pain the interests of consumers value, then this new product also features a listing of the elem